Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,236,561 papers from all fields of science
Search
Sign In
Create Free Account
Donepezil hydrochloride
Known as:
1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hydrochloride
, donepezil hcl
The hydrochloride salt of a piperidine derivative with neurocognitive-enhancing activity. Donepezil reversibly inhibits acetylcholinesterase, thereby…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Alzheimer's Disease
Cytochrome P450 2D6, human
Donepezil hydrochloride 10 MG Oral Tablet
Donepezil hydrochloride 5 MG Disintegrating Oral Tablet [Aricept]
Expand
Narrower (2)
Aricept
Namzaric
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
B. Dubois
,
E. Tolosa
,
+9 authors
M. Moline
Movement Disorders
2012
Corpus ID: 26171446
Parkinson's disease dementia (PDD) is associated with cholinergic deficits. This report presents an efficacy and safety study of…
Expand
Highly Cited
2010
Highly Cited
2010
Electrospun water soluble polymer mat for ultrafast release of Donepezil HCl
Z. Nagy
,
K. Nyúl
,
I. Wagner
,
K. Molnár
,
G. Marosi
2010
Corpus ID: 615289
Electrostatic spinning (Electrospinning, ES) was applied to prepare Donepezil HCl loaded nanofibers as a poten- tial orally…
Expand
Highly Cited
2007
Highly Cited
2007
A randomized, double‐blind, placebo‐controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement
E. Sampson
,
Peter R. Raven
,
+7 authors
C. Ritchie
International Journal of Geriatric Psychiatry
2007
Corpus ID: 41723402
This was a pilot, phase 2a study to assess methodological feasibility and the safety and efficacy of donepezil in preventing…
Expand
Highly Cited
2005
Highly Cited
2005
Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study
B. Ravina
,
M. Putt
,
+7 authors
T. Simuni
Journal of Neurology Neurosurgery & Psychiatry
2005
Corpus ID: 42216522
Objective: To study the safety and efficacy of a cholinesterase inhibitor, donepezil hydrochloride, for the treatment of dementia…
Expand
Highly Cited
2005
Highly Cited
2005
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
M. Hashimoto
,
H. Kazui
,
Keiji Matsumoto
,
Y. Nakano
,
M. Yasuda
,
E. Mori
American Journal of Psychiatry
2005
Corpus ID: 18512219
OBJECTIVE The only approved pharmacological approach for the symptomatic treatment of Alzheimer's disease in Japan is the use of…
Expand
Highly Cited
2003
Highly Cited
2003
Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.
L. Tune
,
P. Tiseo
,
+5 authors
J. Hoffman
The American journal of geriatric psychiatry
2003
Corpus ID: 19931208
OBJECTIVE The authors evaluated the effects of donepezil (10 mg/day) versus placebo on brain glucose metabolism. METHODS This…
Expand
Review
2002
Review
2002
Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor.
H. Sugimoto
,
H. Ogura
,
Y. Arai
,
Y. Limura
,
Y. Yamanishi
Japanese Journal of Pharmacology
2002
Corpus ID: 18194167
A wide range of evidence shows that cholinesterase (ChE) inhibitors can interfere with the progression of Alzheimer's disease (AD…
Expand
Review
2000
Review
2000
Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.
Hachiro Sugimoto
,
Yoshiharu Yamanish
,
Y. Iimura
,
Yoshiyuki Kawakami
Current Medicinal Chemistry
2000
Corpus ID: 15129862
A wide range of evidence shows that acetylcholinesterase (AChE) inhibitors can interfere with the progression of Alzheimer's…
Expand
Highly Cited
2000
Highly Cited
2000
A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments.
Y. Greene
,
P. Tariot
,
+4 authors
J. Noviasky
Journal of Clinical Psychopharmacology
2000
Corpus ID: 13076383
Cognitive dysfunction occurs in up to 65% of patients with multiple sclerosis (MS), but there is no effective treatment for the…
Expand
Highly Cited
1998
Highly Cited
1998
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
S. Rogers
,
R. Doody
,
R. Mohs
,
L. Friedhoff
Archives of Internal Medicine
1998
Corpus ID: 28346768
BACKGROUND Donepezil hydrochloride (Aricept) is a selective acetylcholinesterase inhibitor developed for the treatment of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE